Dr. Brambrink, a professor at Oregon Health and Science University in Portland, will use the Frontiers in Anesthesia Research Award to investigate the long-term consequences of anesthesia exposure in infant monkeys.
“The proposed experiments will address a question that has potentially important public health implications — does exposure of the infant monkey brain to a clinically relevant anesthesia protocol on one occasion or on multiple occasions cause long-term neurobehavioral disturbances?” said Dr. Brambrink.
Dr. Brambrink said he hopes to apply the relevancy of his experimental model to the human condition.
Related Articles on Anesthesia:
Anesthesiologists Face Higher Debt, Limited Options
Congress Passes FDA Safety and Innovation Act With Drug Shortage Provisions
Study: Overweight Patients Receive Excessive Neuromuscular Blockers
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
